SOCS1:一种潜在的攻击性质瘤的诊断和预后标志物,也是免疫治疗的新目标
Chuanshen Gu1,2, Xinyi Chen3, Jiayan Wu1,2
1The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
Medicine
|December 10, 2024
概括
细胞因子信号传递1抑制剂 (SOCS1) 显示为积极性质瘤的诊断和预后标志物具有前途. 这一发现为克服脑瘤免疫障碍提供了新的免疫治疗点.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症生物标志物 癌症生物标志物
背景情况:
- 质瘤是中枢神经系统的侵略性瘤,具有显著的免疫障碍,限制了免疫疗法的有效性.
- 细胞因子信号传递1抑制剂 (SOCS1) 涉及癌症治疗,在高度质瘤中大量存在.
研究的目的:
- 将SOCS1与质瘤免疫检查点进行比较.
- 评估SOCS1作为质瘤的诊断和预后标志物.
- 探索SOCS1作为质瘤免疫治疗的潜在点.
主要方法:
- 在多个数据库中进行全面的基因表达分析和临床数据验证.
- 全癌症分析,功能丰富和基因组变异分析.
- 检查免疫微环境并使用患者临床数据开发预测模型.
主要成果:
- SOCS1与质瘤免疫检查点 (如CTLA4.4) 有显著相似之处.
- SOCS1作为一个独立的预后因素,积极影响质瘤患者的存活率.
- 结合SOCS1的预测模型证明了对预后评估的提高精度.
结论:
- SOCS1是攻击性质瘤的可行的诊断标志物,提高了预后准确度.
- SOCS1代表了克服质瘤诱导的免疫障碍的新型治疗标.
- 向SOCS1提供了一种新的策略,以提高质瘤免疫治疗的有效性.
更多相关视频
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.8K
09:17Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
2.3K
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.